Product catalog
contact us

    KCI BioTech (Suzhou) Inc.
    Tel:0512-69998806
    Ministry of Commerce:0512-69998806-8012
    BD:
    East and South China:Ms. Gu 15378638068
    North China, East China:Mr. Han 18914988667
    Central and Western regions: Ms. Xiang 15828112963
    Project Management Department:0512-69998806-8022
    Tumor business:0512-69998806-8058
    Non tumor business:0512-69998806-8026
    Pathogenic microorganism business:0512-69998806-8037
    Integrated Service Platform:0512-69998806-8022
    Address: Building A2, Xinyang Industrial Park, No. 8 Yanghua Road, Suzhou Industrial Park

Key Model for Drug Development of Atopic Dermatitis

Atopic Dermatitis (AD) is a common chronic, relapsing, inflammatory skin disease, also known as atopic eczema, and was once referred to as atopic dermatitis and genetic allergic dermatitis. Atopic dermatitis can be categorized into two types: simple and mixed, depending on whether it is combined with other allergic diseases. Of these, the simple type of atopic dermatitis manifests only as dermatitis and can be subdivided into endogenous and exogenous types. The disease has a long course, can seriously affect the quality of survival of patients, and is generally not life-threatening.
  We have established stable multiple models of atopic dermatitis, which are suitable for preclinical atopic dermatitis drug research and new drug evaluation.
  If you have a project need and experience more of our professional services, please contact us.

Our services

Model classification

Model Name

Animal species

Atopic dermatitis

Model of atopic dermatitis induced by calcipotriol (MC903)

Mice

Model of atopic dermatitis induced by oxazolone

Mice

Ovalbumin (OVA)-induced model of atopic dermatitis

 

Model of atopic dermatitis induced by ovalbumin (OVA) in combination with calcipotriol (MC903)


Case sharing

Next:Psoriasis